Short Interest in Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Decreases By 89.4%

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) was the recipient of a large drop in short interest in the month of August. As of August 14th, there was short interest totaling 19 shares, a drop of 89.4% from the July 30th total of 180 shares. Based on an average daily volume of 4,928 shares, the short-interest ratio is currently 0.0 days.

Analyst Ratings Changes

CZMWY has been the topic of a number of research reports. UBS Group downgraded shares of Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a report on Tuesday, August 11th. Zacks Research downgraded shares of Carl Zeiss Meditec from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 11th. One investment analyst has rated the stock with a Buy rating, two have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Reduce”.

Carl Zeiss Meditec Trading Down 1.0%

CZMWY stock traded down $0.36 during trading on Tuesday, hitting $37.33. The company had a trading volume of 1,813 shares, compared to its average volume of 4,367. Carl Zeiss Meditec has a 52-week low of $26.65 and a 52-week high of $55.94. The company has a 50 day simple moving average of $33.47 and a 200-day simple moving average of $31.30.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.